Patients with loco-regional NSCLC planned for curative treatment with chemoradiotherapy will be invited to participate in a prospective study; besides routine treatment, the patients will be followed with an ECG and cardiac MR for at least two years after radiotherapy treatment.
Age ≥ 18 Years
Inoperable and histologically/cytologically verified NSCLC.
Planned treatment with curative intent.
Capable of completing study procedures ECG and Cardiac MR.
Vulnerable patients.
Patients with operable devices as pacemaker/ICD and cochlear implant or other conditions where MR scan is contraindicated.
Claustrophobia.